Moderna Shares Slump Amid Concerns Over COVID-19 Vaccine Demand

The company stated that it’s ‘still too early’ to project vaccination rates for the full year.
Moderna Shares Slump Amid Concerns Over COVID-19 Vaccine Demand
The Moderna COVID-19 vaccination prepared at Lestonnac Free Clinic in Orange, Calif., on March 9, 2021. John Fredricks/The Epoch Times
Jack Phillips
Jack Phillips
Breaking News Reporter
|Updated:
0:00

Shares of pharmaceutical company Moderna have slumped again amid concerns about COVID-19 vaccine demand in the United States.

Over the past five days, shares of the company dropped about 18 percent, while over the past month, the stock has decreased by 20 percent. For all of 2023, meanwhile, shares of Moderna have plummeted by 54 percent.

Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics